[Dysarthria?]

Rev Neurol (Paris). 2003 Apr;159(4):466-9.

[Article in French]

Authors

C Ozsancak¹, P Auzou

Affiliation

¹ Service de Neurologie et Pathologie du Mouvement, Hôpital Roger Salengro, CHRU de Lille, Lille.

PMID: 12773881

No abstract available

Publication types

Review

MeSH terms

Botulinum Toxins, Type A / therapeutic use
Cholinesterase Inhibitors / therapeutic use
Diagnosis, Differential
Dysarthria / classification
Dysarthria / diagnosis*
Dysarthria / etiology
Dysarthria / therapy
Humans
Language Disorders / diagnosis
Laryngeal Diseases / complications
Myasthenia Gravis / complications
Myasthenia Gravis / drug therapy
Nervous System Diseases / complications
Neuromuscular Diseases / complications
Neurosurgical Procedures
Speech Intelligibility
Speech Production Measurement
Stroke / complications

Substances

Cholinesterase Inhibitors
Botulinum Toxins, Type A